Stephanie Mgebroff

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Apr 15, 2025
Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL.

Colleen Annesley, Kristy Seidel, Qian Wu

|Aug 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL.

Colleen Annesley, Adam Lamble, Corinne Summers

|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.

Francesco Ceppi, Ashley L Wilson, Colleen Annesley

Pageof 1

Frequent Collaborators

4 joint publications

Julie R Park

4 joint publications

Wenjun Huang

4 joint publications

Rebecca Gardner

3 joint publications

Michael A Pulsipher